Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1C03XA01----2件: 67, 72 💬
2Desmopressin1件: Desmopressin1件: Desmopressin 💬 2件: AVPR2,
F8 💬 		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬5件: 6, 64, 72, 225, 288 💬
3Desmopressin intranasal1件: Desmopressin1件: Desmopressin 💬 2件: AVPR2,
F8 💬 		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
4Desmopressin Oral Melt1件: Desmopressin1件: Desmopressin 💬 2件: AVPR2,
F8 💬 		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
5Empagliflozin1件: Empagliflozin1件: Empagliflozin 💬 1件: SLC5A2 💬 -6件: 58, 65, 67, 72, 97, 257 💬
6Empagliflozin 25 MG1件: Empagliflozin1件: Empagliflozin 💬 1件: SLC5A2 💬 -1件: 72 💬
7Empagliflozin 25mg1件: Empagliflozin1件: Empagliflozin 💬 1件: SLC5A2 💬 -1件: 72 💬
8Empagliflozin 25mg Tbl1件: Empagliflozin1件: Empagliflozin 💬 1件: SLC5A2 💬 -1件: 72 💬
9EXENATIDE1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 6, 17, 72, 78, 193, 233 💬
10Experimental: CRH administration----2件: 72, 78 💬
11Experimental: GLP1-RA (exenatide) administration1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 72, 78 💬
12IUPAC----1件: 72 💬
13Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬12件: 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬
14Oxytocin1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬7件: 6, 72, 127, 168, 193, 206, 226 💬
15Oxytocin nasal spray1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬2件: 72, 193 💬
16Samsca1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬2件: 67, 72 💬
17SAMSCA*10CPR 15MG1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
18Satavaptan1件: Satavaptan---1件: 72 💬
19Satavaptan (SR121463)1件: Satavaptan---1件: 72 💬
20Satavaptan (SR121463B)1件: Satavaptan---1件: 72 💬
21SR121463B----1件: 72 💬
22TOLVAPTAN1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬4件: 67, 72, 86, 225 💬
23Tolvaptan (SAMSCA)1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
24Tolvaptan in euvolemic hyponatremia1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
25Tolvaptan Oral Tablet1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
26Urea1件: Urea2件: Urea ,
Urea C13 💬 		--2件: 72, 251 💬